Project ADAPT (Space Health)

About Fauna Bio

Fauna Bio is a private, preclinical-stage biotech founded in 2018 and headquartered in Emeryville, California. The company has pioneered a unique drug discovery platform that mines genetic data from a proprietary biobank of extreme mammals to find novel targets for diseases like obesity, fibrosis, and muscle wasting. Its business model is a hybrid of platform licensing and therapeutic development, evidenced by a significant $494M+ partnership with Eli Lilly in obesity. Fauna Bio also engages in innovative space health research funded by NASA and other space agencies, exploring the protective effects of hibernation for astronauts.

Therapeutic Areas